The case for giving medical marijuana to children
The plight of a New Jersey 2-year-old is sparking a debate that could result in new legislation to loosen the state's current law.
The issue has come to a head in New Jersey, where Meghan and Brian Wilson are trying to get medical marijuana treatment for their 2-year-old Vivian (pictured), who's afflicted with a rare, debilitating form of epilepsy called Dravet syndrome. The Wilsons are pushing state legislators to pass a law making it easier for minors to get that access. They're being opposed by the American Academy of Pediatrics' New Jersey chapter and a skeptical Gov. Chris Christie.
"According to current state law, any doctor who wants to prescribe medical marijuana to a child must have a pediatrician and a psychiatrist vet his decision," according to New Jersey Spotlight. "That's a particularly daunting challenge in New Jersey, where only two pediatricians have registered with the state's nascent medical marijuana program."
The American Academy of Pediatrics argues that scant scientific data are available on marijuana's effectiveness, an argument that advocates dispute. And NORML (National Organization to Reform Marijuana Laws) points out that very few children currently are given legal access to the drug in states where it is allowed.
"The reality is that various substances commonly prescribed to adolescents (e.g., Ritalin) in the marketplace were never clinically tested on young adult subjects and the long-term effects of these substances on young adult users is largely unknown," writes NORML deputy director Paul Armentato, in an email to MSN moneyNOW. By comparison, he notes, "well over 22,000 papers on marijuana appear in the peer-reviewed literature."
New Jersey has among the strictest medical marijuana laws in the country, if not the strictest, because Christie, a former U.S. Attorney, was afraid it was going to be abused by "potheads." Any doctor who wants to prescribe medical marijuana to a child must have a pediatrician and a psychiatrist vet that decision, requirements that some see as overly burdensome. A bill pending in the legislature would treat children the same as adults.
Patients with epilepsy, such as "Vivie" Wilson, are entitled to get cannabis legally. But as the Philadelphia Inquirer noted, New Jersey's one legal dispensary restricts sales to residents in the Northern part of the state. The toddler lives in the central part.
The Wilsons told the newspaper they wouldn't allow Vivie to smoke the cannabis. Instead, they would give it to her as an extract that can be put into food. Such a formulation is available in Colorado and California, according to the Inquirer.
Marijuana has reduced the duration and intensity of the seizures suffered by 14-year-old Jackson Stormes after more conventional therapies such as brain surgery failed, according to New Jersey Spotlight. He has developmental problems and can't speak.
If more children can get access to medical marijuana, it could open a new market for the growing industry, which one forecast estimates will top $3 billion in 2014, double what it is today.
Follow Jonathan Berr on Twitter @jdberr.
Lets dope her up with really good chemicals that kill off organs.
If cannabis has the medical benefits the pro-marijuana lobby claims it has, then why have the chemicals with the benefits never been isolated? Why has it never been available in pill form?
Why not just give this toddler a big fat joint? That's what all you pro-marijuana people want, right???
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
[BRIEFING.COM] The stock market welcomed the new trading week with a mixed session that saw relative strength among large-cap stocks, while high-beta names underperformed. The Dow Jones Industrial Average (+0.3%) and S&P 500 (-0.1%) finished near their flat lines, while the Nasdaq Composite and Russell 2000 both lost 1.1%.
Equities began the day on a cautious note amid continued concerns regarding the strength of the global economy. Over the weekend, China reported its first decline ... More
More Market News
Stocks drift lower and bonds are hit as investors await the Fed. Prepare for higher volatility this week.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'